|
Drug
Search
Shopping
Cart
|
Nov Canadian Pharmacy News
Issue #4, November 2003
Medisave.ca Now Ships Memantine to Treat
Alzheimer's
|
Memantine
Dose:
|
10mg
|
Quantity:
|
100
|
Price:
|
$335.00
|
|
Memantine
Dose:
|
10mg
|
Quantity:
|
50
|
Price:
|
$184.00
|
Order
Memantine Online Now
Medisave now ships Memantine to the U.S.A. within 14 days at the
most affordable price.
Memantine
is a substance developed by the Merz research organization and is
successfully used to treat dementia. Clinical data show that Memantine
also known as Namenda provides rapid and enduring improvement in
the cognitive, psychological, social and motor impairments of Alzheimers,
Dementia and Parkinson's disease. These symptomatic improvements
lead to an increased quality of life of the patients and reduces
home care efforts. Successfully used to treat dementia.
Alzheimer's is a progressive disease of the brain and it is the
most common type of dementia. The term dementia is used to describe
the progressive loss of cognitive, intellectual, or functional abilities.
Published reports project that by 2010 more than 5.1 million people
in the United States will have Alzheimer's disease. Currently, all
Alzheimer's medications approved in the United States belong to
a class of agents called acetylcholinesterase inhibitors, which
are indicated for patients with mild to moderate symptoms of the
disease. Namenda is the only approved therapy in the United States
for moderate to severe Alzheimer's disease.
Top of the page
Illinois Governor Rod Blagojevich wants
review of drugs made by companies limiting supplies to Canada
By Maura Kelly
Associated Press Writer November 25, 2003
CHICAGO--Gov. Rod Blagojevich on Tuesday plans to announce that
Illinois will remove from its preferred drug lists any brand-name
drugs made by companies that threaten to limit supplies to Canada,
if safe equivalents are available, a spokeswoman for Blagojevich
said. Five major drug companies have placed controls on their drug
sales to Canadian pharmacies in trying to prevent their medications
from being reimported and sold to consumers in the United States,
spokeswoman Abby Ottenhoff said.
"We're not going to stand by and let them muscle American consumers.
The government is sending a message that wealthy drug companies
can't play games at consumers' expense," Ottenhoff said. The five
companies Ottenhoff cited are AstraZeneca, Eli Lilly & Co., GlaxoSmithKline,
Pfizer Inc. and Wyeth of Madison, N.J.
Top of the page
"We're disappointed with the governor's announcement today," AstraZeneca
spokeswoman Rachel Bloom-Baglin said. "It is still illegal to import
drugs from foreign countries, Canada included." AstraZeneca Canada
put an allotment system in place in April to ensure there is an
adequate drug supply for Canadian patients, she said. Also, she
said Illinois has told AstraZeneca that decisions about the state's
preferred drug lists were primarily based on whether drugs offer
clinical benefits to patients, not on price. "If the administration
were to move forward with this proposal, it would appear to run
counter to those representations," Bloom-Baglin said.
Blagojevich
commissioned a report that said Illinois would save as much as $91
million if state employees and retirees bought drugs from Canada,
which is illegal. Illinois spent $340 million on prescription drugs
for its employees and retirees last fiscal year, a 15 percent increase
from the previous year. The U.S. Food and Drug Administration criticized
that report for inflating savings and wrongly assuming Canadian
health authorities can guarantee the safety of drugs sent to the
United States.
Brand-name drugs often cost less in Canada because of government
price controls. The Associated Press has reported that its own survey
of comparable U.S. and Canadian prices for 10 popular drugs found
the Canadian prices were 33 percent to 80 percent cheaper. The FDA
and pharmaceutical companies warn that buying Canadian drugs presents
significant potential health and safety risks.
Top of the page
Blagojevich plans to instruct the advisory committees of 12 state
healthcare programs, which establish the list of drugs that are
covered by each program, to look for alternatives to replace drugs
on their lists that are made by the five companies, Ottenhoff said.
The committees will make recommendations within 45 days to the state's
two special advocates on prescription drugs, who will make final
decisions on which drugs to replace, Ottenhoff said. "We're disappointed
that again he is seeking to find a way to import prescription drugs
when the FDA has made very clear it threatens the safety of the
drug supply," Lilly spokesman Rob Smith said. Smith did not know
if Blagojevich's decision would hurt Lilly, adding that he did not
know details of the governor's plan.
"Anything that would weaken the web of protection we have around
our drug supply would be problematic for patients," he said.
Top of the page
Place
Your Order Before the Holiday Rush
Please place your
orders before the holiday rush. This is an early reminder that during
the holiday season, the Post Office and US customs experience a large
increase in the volume of packages that are being shipped. We suggest
that you place your orders at least 4 weeks before you want to receive
them during this busy season.
Top of the page
Medisave Launches Revamped Website with Enhanced
Functionality
Join Now and Save
Today !
MediSave.ca is pleased to release several enhancements
to our website. The website has been revamped to enable our clients
to experience a more user-friendly online shopping experience. Our
website now has a complete shopping cart system whereby customers
can order their specific medications and quantities online, fax
their prescription and have the order delivered within 10 days.
New Customers
- Click Here
to Join Today
Existing Customers - Click
Here to Fill Out New Form Today
Please visit our website to take a firsthand look at how our online
shopping system now works. New and Existing customers can now join
and order directly online. Please enjoy this new prescription shopping
experience. Visit the following page to fill out your Personal
Patient Profile Page and begin saving today.
Medisave
Membership Page - Fill out a Patient Profile form, retain a
membership login password and become a Medisave.ca member for life
where your health is our concern.
Let Us Know What You Think
We would love to hear what you think of this issue of
our newsletter and our prescription service. And of course, if you
have any suggestions for upcoming issues that you'd like to share
with us, please send those too! E-mail us at customerservice@medisave.ca
|